Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 13, 2021Journal of Hypertension and CardiologyOpen Access

Understanding the multilayered regulation of protein expression, mutations, microRNAs, and epigenetics is necessary to link genetics with cardiovascular disease onset and develop effective therapies.

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Understanding the role of genetics in cardiovascular disease development has become critical to link genetics with disease onset and response to therapy, beyond conventional environmental risk factors.

Design

Review

Authors

AEAbdu EsmaelTTTesfaye Sisay Tessema

Discussion

Loading...

Member takes

Overview

Genetic insights may refine CVD risk assessment; leaves open whether testing improves outcomes beyond traditional factors.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Esmael et al. (2021) studied this question.

synapsesocial.com/papers/6a7d23752ad457ac68775285https://doi.org/10.14302/issn.2329-9487.jhc-21-3742
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Genomics of Cardiovascular Disease2009 · 16 citations
  2. 2Genetics and pharmacogenetics in the diagnosis and therapy of cardiovascular diseases.2019 · 20 citations
  3. 3Molecular genetics: Cardiac disease and risk-related genes-Genetic risk factors1995 · 5 citations
  4. 4The molecular genetics of cardiovascular disease: clinical implications2003 · 93 citations
  5. 5Genetics and Genomics for the Prevention and Treatment of Cardiovascular Disease: Update2013 · 127 citations